FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for fentanyl transdermal submitted by SpecGx LLC, resulting in a regulatory update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain
• Pain

Drugs mentioned

• Fentanyl transdermal (fentanyl transdermal system)

Snippet

SUPPL AP for FENTANYL TRANSDERMAL (FENTANYL TRANSDERMAL)